Cardinal Health price target raised to $180 from $175 at Evercore ISI

Evercore ISI raised the firm’s price target on Cardinal Health (CAH) to $180 from $175 and keeps an Outperform rating on the shares after attending the company’s Investor Day event. Cardinal’s long-term guidance remains unchanged, and Evercore ISI sees continued potential upside to the firm’s estimates given the company’s strong execution, deployment of improved free cash flow, and multipronged growth outlook with particular potential upside from specialty, nuclear/other, the analyst tells investors in a research note.